Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,243 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

for
KRAS P.G12C
Location: Nashville TN, Detroit MI, Sarasota FL, Houston TX,
Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All

Age: 18+

Code: NCT05410145

Phase 1, Phase 2, Recruiting

Impact of Pelvic Pain Podcast

for
Chronic Pelvic Pain, Endometriosis
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: Female

Age: 18+

Code: NCT07568834

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Nashville TN, Germantown TN, Atlanta GA, Cincinnati OH,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

The JULI Registry--Hemp and Cannabis Observational Registry

for
Chronic Pain, Appetite Disorders, Neuropathy,
Location: Nashville TN, Dallas TX, San Jose CA, Los Gatos CA
Sponsor: Juva Life

Sex: All

Age: 21+

Code: NCT04726254

Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Nashville TN, Owensboro KY, Bardstown KY, New Albany IN,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Nashville TN, Cordova TN, Birmingham AL, Smyrna GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase 3, Recruiting

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Nashville TN, Columbus OH, New York NY, Mineola NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05422794

Phase 1, Recruiting

The PREDICT Registry:

for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Nashville TN, Atlanta GA, St Louis MO, Columbus OH,
Sponsor: PreludeDx

Sex: Female

Age: 30 - 70+

Code: NCT03448926

Recruiting

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

for
Fecal Incontinence
Location: Nashville TN, Cincinnati OH, Houston TX
Sponsor: Axonics, Inc.

Sex: All

Age: 18+

Code: NCT07499258

Recruiting

Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

for
Skin Laxity (Submental and Neck), Facial Skin Laxity,
Location: Nashville TN, Charlotte NC, Wilmington NC, Spokane WA,
Sponsor: CLASSYS Inc.

Sex: All

Age: 30 - 65

Code: NCT07229430

Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

for
Obesity, Overweight, Chronic Weight Management,
Location: Nashville TN, Woodstock GA, Birmingham AL, Atlanta GA,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07654374

Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for
Narcolepsy, Idiopathic Hypersomnia
Location: Nashville TN, Birmingham AL, Cincinnati OH, Denver NC,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase 3, Recruiting

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

for
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Location: Nashville TN, Gainsville GA, Columbus GA,
Sponsor: Lighthouse Pharmaceuticals, Inc.

Sex: All

Age: 55 - 70+

Code: NCT06847321

Phase 2, Recruiting
New

Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease

for
Preclinical Alzheimer's Disease
Location: Nashville TN
Sponsor: NewAmsterdam Pharma

Sex: All

Age: 55 - 70+

Code: NCT07794670

Phase 2, Recruiting

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

for
Degenerative Disc Disease, Lumbar Disc Disease, Spine Disease,
Location: Nashville TN, Fort Wayne IN, Pinehurst NC
Sponsor: Locate Bio Pty Ltd

Sex: All

Age: 22 - 70+

Code: NCT06462729

Phase 1, Phase 2, Recruiting

Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion

for
Degenerative Disc Disease, Spine Fusion, Back Pain
Location: Nashville TN, St Louis MO, Grand Rapids MI,
Sponsor: Kuros Biosurgery AG

Sex: All

Age: 18+

Code: NCT04679844

Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Nashville TN, Jeffersonville IN, Cincinnati OH,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Nashville TN, Jeffersonville IN, Germantown TN,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase 2, Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Nashville TN, Jeffersonville IN, Charlotte NC,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase 3, Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Nashville TN, Birmingham AL, Atlanta GA, Durham NC,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07206225

Phase 1, Recruiting